•Trivium’s enterprise value is about $3.4 billion, or 7.1 times adjusted EBITDA for the trailing 12 months, falling to 4.8 times with expected synergies included.
•Silgan will retain a controlling 60% stake in the metal platform, compared with 40% for American Industrial Partners.
•Silgan expects $225 million in synergies by the end of the third year and adjusted earnings per share at least 15% higher.
•The Infra and HUMAIN agreements are worth up to SAR 2.5 billion, or about $667 million, and were announced on November 9, 2026, after being signed in Riyadh on November 8.
•The GPU purchase facility is worth up to SAR 1.1 billion and is tied to an IT load of about 25 megawatts.
•The power infrastructure facility is worth up to SAR 1.4 billion, and the infrastructure is designed to support future IT capacity of up to 1 gigawatt.
•The investment program is worth about $7.3 billion over the life of the concession, including $1.5 billion expected from 2027 to 2031.
•Aeropuertos Argentina will provide $600 million in direct funding, while the remaining investments will be financed by funds funded through a concession fee equal to 15% of gross revenue.
•The domestic passenger usage charge rises to $9 starting December 10, 2026.
•Moody’s affirmed Nvidia’s senior unsecured rating at Aa1 and its commercial paper rating at Prime-1, and cut its outlook to stable from positive on November 18, 2026.
•Moody’s considers a rating upgrade unlikely over 12 to 18 months.
•Nvidia’s quarterly revenue was $115.8 billion, up 20% quarter over quarter and 103% year over year.
•The six patients eligible for response assessment achieved an objective response: five complete responses and one partial response, with a 58% decline in tumor measurements.
•All eight treated patients were alive as of November 11, and median follow-up among the six patients eligible for assessment was 6.9 months.
•The three most recent responses need confirmation in later scans; the first three complete responses were confirmed.
•Phathom’s net revenue was $84.7 million in the third quarter of 2026, up 71% year over year and 14% quarter over quarter.
•VOQUEZNA prescriptions dispensed exceeded two million from launch through October 16, 2026, with about 380,000 prescriptions recorded in the third quarter.
•Phathom recorded a GAAP net loss of $13.9 million and adjusted net income of $3.0 million in the third quarter.
•Two MercadoLibre subsidiaries signed unsecured loan agreements totaling $735 million, split equally between them.
•The International Finance Corporation will finance $250 million, and participating institutions will provide $485 million.
•The proceeds are earmarked for the early settlement of credit card receivables for micro, small and medium-sized businesses in Brazil’s Amazon region.
•Adjusted net foreign purchases of long-term U.S. securities totaled $155.3 billion in September, compared with $285.0 billion in August.
•Net dollar-denominated portfolio flows into the United States reached $261.0 billion in September, including $267.0 billion in private flows and net official outflows of $6.0 billion.
•Unadjusted net foreign purchases of long-term U.S. securities totaled $186.7 billion in September.